Liquid pharmaceutical formulations of palonosetron

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9439854
APP PUB NO 20150306032A1
SERIAL NO

14793233

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELSINN THERAPEUTICS (U S ) INC170 WOOD AVENUE SOUTH 5TH FLOOR ISELIN NJ 08830
HELSINN ADVANCED SYNTHESIS SAVIA INDUSTRIA BIASCA CH-6710
HELSINN BIREX PHARMACEUTICALS LTDDAMASTOWN MULHUDDART DUBLIN 15

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonadeo, Daniele Casalzuigno, IT 44 371
Calderari, Giorgio Rancate, CH 25 115
Cannella, Roberta Varese, IT 39 157
Lee, Kathleen M Palo Alto, US 22 128
Macciocchi, Alberto Melide, CH 15 55
Malefyt, Thomas Carmel Valley, US 18 93
Miksztal, Andrew Palo Alto, US 18 99

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00